Cardiac Biomarkers and Mortality in Critically Ill Patients With SARS-CoV-2 (COVID-19)

N/ACompletedNCT04641988

University Hospital, Montpellier111 enrolled

Overview

Objective: To assess the prognostic value of high-sensitive cardiac troponin T (hs-cTnT) and N-terminal pro brain natriuretic peptide (NT-proBNP) at ICU admission in patients with coronavirus disease 2019 (COVID-19). Design: Multicenter retrospective observational cohort study Setting: Three ICUs at three hospitals in Occitanie, France. Patients: Adults (≥ 18 years old) with laboratory-confirmed COVID-19 and at least one hs-cTnT measurement at ICU admission, from March 9, 2020, to May 9, 2020.

Study Type

OBSERVATIONAL

Enrollment

111

Conditions

COVID-19

Eligibility

Sex: ALLMin age: 18 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion criteria: \- Adults (≥ 18 years old) with laboratory-confirmed COVID-19 and at least one hs-cTnT measurement at ICU admission Exclusion criteria: \- Age \< 18, pregnancy

Locations (1)

Uhmontpellier

Montpellier, France

Outcomes

Primary Outcomes

hs-cTnT

Time frame: at ICU admission

Secondary Outcomes

NT-proBNP

Time frame: at ICU admission

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.